Related references
Note: Only part of the references are listed.Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
Renato D. Lopes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials
Renato D. Lopes et al.
JAMA CARDIOLOGY (2019)
Mathematical modelling of the restenosis process after stent implantation
Javier Escuer et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2019)
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease
Satoshi Yasuda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Photoelasticity-based evaluation of cellular contractile force for phenotypic discrimination of vascular smooth muscle cells
Shukei Sugitat et al.
SCIENTIFIC REPORTS (2019)
Initial pathological responses of second-generation everolimus-eluting stents implantation in Japanese coronary arteries: Comparison with first-generation sirolimus-eluting stents
Rika Kawakami et al.
JOURNAL OF CARDIOLOGY (2018)
Correlation between pre-procedural plaque morphology and patterns of in-stent neointimal hyperplasia at 1-year follow-up in patients treated with new-generation drug-eluting stents: An optical coherence tomography based analysis
Shun-Yi Shi et al.
JOURNAL OF INTERVENTIONAL CARDIOLOGY (2018)
Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy
C. Michael Gibson et al.
CIRCULATION (2017)
Early endothelialization associated with a biolimus A9 bioresorbable polymer stent in a porcine coronary model
Masayuki Mori et al.
HEART AND VESSELS (2017)
GEMINI-ACS-1: toward unearthing the antithrombotic therapy cornerstone for acute coronary syndromes
Paul A. Gurbel et al.
LANCET (2017)
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
E. Magnus Ohman et al.
LANCET (2017)
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
J. W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
C. Michael Gibson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Comparison of neointimal coverage between everolimus-eluting stents and sirolimus-eluting stents: an optical coherence tomography substudy of the RESET (Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial)
Takashi Kubo et al.
EuroIntervention (2015)
Long-Term Outcomes of Neointimal Hyperplasia Without Neoatherosclerosis After Drug-Eluting Stent Implantation
Jung-Sun Kim et al.
JACC-CARDIOVASCULAR IMAGING (2014)
Neointimal patterns obtained by optical coherence tomography correlate with specific histological components and neointimal proliferation in a swine model of restenosis
Jung-Sun Kim et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2014)
Biological responses in stented arteries
Chiraz Chaabane et al.
CARDIOVASCULAR RESEARCH (2013)
Reduction of Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Rivaroxaban in ATLAS-ACS 2 TIMI 51
C. Michael Gibson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial
Willem J. M. Dewilde et al.
LANCET (2013)
Effects of rivaroxaban, acetylsalicylic acid and clopidogrel as monotherapy and in combination in a porcine model of stent thrombosis
E. M. Becker et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
Jessica L. Mega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Triple antiplatelet therapy vs. dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: an evidence-based approach to answering a clinical query
Inderjeet Singh et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Effect of clopidogrel on the inflammatory progression of early atherosclerosis in rabbits model
Ming Li et al.
ATHEROSCLEROSIS (2007)
Regulation and characteristics of vascular smooth muscle cell phenotypic diversity
S. S. M. Rensen et al.
NETHERLANDS HEART JOURNAL (2007)
Comparison of processing and sectioning methodologies for arteries containing metallic stents
P Rippstein et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2006)
Molecular basis of restenosis and drug-eluting stents
MA Costa et al.
CIRCULATION (2005)
Inflammation and restenosis after percutaneous coronary interventions
K Toutouzas et al.
EUROPEAN HEART JOURNAL (2004)
Arterial smooth muscle cell heterogeneity - Implications for atherosclerosis and restenosis development
HY Hao et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Drug eluting stents: are human and animal studies comparable?
R Virmani et al.
HEART (2003)
Drug-eluting Stents in preclinical studies - Recommended evaluation from a consensus group
RS Schwartz et al.
CIRCULATION (2002)
A synthetic inhibitor of factor Xa, DX-9065a, reduces proliferation of vascular smooth muscle cells in vivo in rats
B Kaiser et al.
THROMBOSIS RESEARCH (2000)
Platelets and restenosis
B Chandrasekar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
Share Paper
